Ondansetron Sandoz

Ondansetron, the active ingredient in Ondansetron Sandoz, is a serotonin 5‑HT3 receptor antagonist presented as a tablet for oral use. It is employed to prevent and treat nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron Sandoz is used to control nausea and vomiting by acting on the serotonergic pathways involved in emesis. - Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: prevents onset of symptoms during and after radiotherapy. - Postoperative nausea and vomiting: helps maintain patient comfort and reduces the need for rescue antiemetics.

Ondansetron may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Dizziness: sensation of light‑headedness. - Fatigue: feeling unusually tired. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - QT interval prolongation: may lead to cardiac arrhythmia. - Severe allergic reactions: rash, swelling, anaphylaxis. - Serotonin syndrome: agitation, hyperthermia, neuromuscular abnormalities. - Cardiac arrhythmia: irregular heart rhythm beyond QT changes. - Hepatic dysfunction: elevated liver enzymes. - Neutropenia: reduced white blood cell count.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Cardiac assessment: review history of arrhythmias or prolonged QT. - Electrolyte monitoring: correct hypokalaemia or hypomagnesaemia. - Hepatic impairment: adjust use in patients with liver disease. - Concomitant QT‑prolonging drugs: avoid or monitor closely. - Renal function: consider dose adjustment in severe renal insufficiency. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ondansetron interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Apomorphine: may cause profound hypotension. - Other QT‑prolonging agents (e.g., quinidine, erythromycin): increase risk of cardiac arrhythmia. - Carbamazepine: induces metabolism, reducing ondansetron efficacy. - Aprepitant: CYP3A4 interaction may alter plasma levels. - Ritonavir: strong CYP3A4 inhibitor, may raise ondansetron concentrations.

Moderate Interactions (Monitor Closely): - SSRIs/SNRIs: combined use can precipitate serotonin syndrome. - Ketoconazole: may increase ondansetron exposure. - Phenytoin: may lower ondansetron levels. - Digoxin: potential increase in serum digoxin. - Warfarin: possible effect on INR, requiring monitoring.